<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000635746"><TermName>procarbazine hydrochloride</TermName><TermPronunciation>(proh-KAR-buh-zeen HY-droh-KLOR-ide)</TermPronunciation><TermDefinition><DefinitionText>A drug that is used to treat advanced Hodgkin lymphoma and is being studied in the treatment of other types of cancer. Procarbazine hydrochloride blocks cells from making proteins and damages DNA. It may kill cancer cells. It is a type of antineoplastic agent and a type of alkylating agent. Also called Matulane.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722848" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;procarbazine hydrochloride&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722847" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;clorhidrato de procarbazina&quot;" language="es" id="_4"/><SpanishTermName>clorhidrato de procarbazina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el linfoma de Hodgkin en estadio avanzado y que está en estudio para el tratamiento de otros tipos de cáncer. El clorhidrato de procarbazina impide que las células elaboren proteínas y daña el ADN. Podría destruir células cancerosas. Es un tipo de antineoplásico y un tipo de alquilante. También se llama Matulane.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-20</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000675532">Procarbazine Hydrochloride</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
